Introduction
The 21st proteinogenic amino acid, selenocysteine (Sec), is a constituent of more than 25 human selenoproteins. Sec incorporation requires UGA codons in selenoprotein mRNAs to be decoded as Sec, preventing their usual interpretation as termination codons targeting many mRNAs for nonsense-mediated decay (NMD) (1, 2) . This is achieved via a unique, highly conserved, Sec-insertion machinery comprising trans-acting factors (e.g., SECIS binding protein 2 ) interacting with cis-acting Sec-insertion sequence (SECIS) elements, located in the 3′ UTR of most eukaryotic selenoprotein mRNAs ( Figure 1 ). Mutations in SECISBP2 cause a multisystem disorder with myopathic features due to selenoprotein N (SEPN1) deficiency, increased ROS attributable to lack of antioxidant selenoenzymes -glutathione peroxidases (GPxs) and thioredoxin reductases (TrxRs) -and thyroid dysfunction secondary to loss of selenoprotein deiodinases (3, 4) ; O-phosphoseryl-tRNA:Sec tRNA synthase (SEPSECS) defects cause progressive cerebellocerebral atrophy, likely reflecting global disruption of selenoprotein synthesis (5, 6) .
Results and Discussion
An 8-year-old male (the proband), investigated for symptoms including abdominal pain, fatigue, and muscle weakness, exhibited thyroid dysfunction (raised T4, normal T3, raised reverse T3) suggestive of impaired deiodinase activity in combination with low plasma selenium levels, reflecting deficiencies of circulating red cell GPx, plasma GPx, and selenoprotein P (SEPP1) ( Table 1 and Figure 2B) , as seen in cases with SECISBP2 mutations. Muscle imaging showed mild signal intensity change (Supplemental Figure 1A ; supplemental material available online with this article; doi:10.1172/ JCI84747DS1), with negligible SEPN1 expression in his dermal fibroblasts ( Figure 2B ). Endogenous H 2 O 2 levels in fibroblasts from the proband and a SECISBP2-deficient patient were comparably elevated, consistent with impaired antioxidant defence in both contexts (Supplemental Figure 1B) . However, comparison of selenoprotein expression profiles revealed significant differences, with preservation of housekeeping selenoproteins (e.g., TrxRs, Figure 2 , A and B; GPx4, Figure 2B ) in cells from the proband compared with SECISBP2 deficiency cases. In contrast, expression of stress-related selenoproteins (e.g., GPx1, GPx3, SEPW1) was similarly reduced in both contexts. Furthermore, comparison of mRNA expression patterns indicated markedly reduced transcript levels for some selenoproteins in SECISBP2 deficiency cases, consistent with known propensity to NMD-mediated mRNA instability in this context (1, 4) , whereas selenoprotein mRNA levels in the proband were either normal or slightly increased ( Figure 2C ). These findings, together with normal SECISBP2 protein expression in the proband ( Figure  2B ) and failure to identify abnormalities with SECISBP2 sequencing, suggested a defect elsewhere in the Sec-insertion pathway.
Homozygosity mapping in this family with known parental consanguinity identified a single interval in the proband, encomSelenium is a trace element that is essential for human health and is incorporated into more than 25 human selenocysteinecontaining (Sec-containing) proteins via unique Sec-insertion machinery that includes a specific, nuclear genome-encoded, transfer RNA (tRNA
). Here, we have identified a human tRNA [Ser] Sec mutation in a proband who presented with a variety of symptoms, including abdominal pain, fatigue, muscle weakness, and low plasma levels of selenium. This mutation resulted in a marked reduction in expression of stress-related, but not housekeeping, selenoproteins. Evaluation of primary cells from the homozygous proband and a heterozygous parent indicated that the observed deficit in stress-related selenoprotein production is likely mediated by reduced expression and diminished 2′-O-methylribosylation at uridine 34 in mutant tRNA . This study identifies a tRNA mutation that selectively impairs synthesis of stress-related selenoproteins and demonstrates the importance of tRNA modification for normal selenoprotein synthesis.
Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis Erik Schoenmakers, The Journal of Clinical Investigation Figure 3B ), possibly affecting codon-anticodon interaction in the ribosomal complex. The relative preponderance of these isoforms is influenced by systemic selenium status (7) (8) (9) , and each subtype has a differing role in selenoprotein synthesis. Synthesis of housekeeping selenoproteins (e.g., TrxR1, TrxR3, GPx4) is dependent on the mcm 5 U isoform, whereas production of stressrelated selenoproteins (e.g., GPx1, GPx3, SEPW1) is directed by the mcm 5 Um species (1, 8) . These 2 tRNA
[Ser]Sec populations were quantitated and resolved chromatographically in patient-derived passing the chromosomal locus of only 1 gene (TRU-TCA1-1) in the Sec-incorporation pathway, encoding tRNA
[Ser]Sec ( Figure  3A) . Sequencing of this single-copy gene (Supplemental Table 1 ) in the proband indicated homozygosity for a single nucleotide change (C65G) ( Figure 3B) ; the nucleotide change (not found in 60,000 exome [Exome Aggregation Consortium (ExAc)] and other published data sets) segregated with phenotype, with unaffected parents and 1 sibling being heterozygous (Table 1) . Additional nucleotide changes outside the coding region corresponded to recognized SNPs that did not segregate with phenotype (Supplemental Figure 2) .
Quantitative analyses in primary cells from the homozygous proband and heterozygous parent indicated generation of both WT and C65G mutant tRNA U is partially methylated by an unidentified Um34 methylase, and the level of methylation is dependent on selenium status (7, 9) . A multiprotein complex containing tRNA selenocysteine 1 associated protein 1 (TRNAU1AP), EEFSEC, and Sec-tRNA
[Ser]Sec isoform by SECISBP2, wherein SECISBP2 is bound to the SECIS stem loop element located in the 3′ UTR of mammalian selenoprotein mRNAs decoding UGA Sec codons at the ribosomal acceptor site to mediate Sec incorporation into nascent polypeptide. Other factors, such as ribosomal protein L30 (RPL30), eukaryotic translation initiation factor 4A3 (EIF4A3), and nucleolin (NCL), also regulate the Sec insertion process (1, 2, 7) . Figure 3C and Supplemental Figure 3 ). The basis for such reduction in mutant tRNA
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[Ser]Sec levels is unclear, but possibilities include anomalous transcription and greater mutant transcript turnover or transcript degradation secondary to defective mutant tRNA [Ser] Sec maturation. Preserved selenoprotein levels in heterozygous parents ( Figure  2A ) suggest that moderate reduction in tRNA
[Ser]Sec levels is not rate limiting for selenoprotein biosynthesis, as has been documented in other contexts (8) . However, in the proband, much lower levels of tRNA [Ser] Sec were sufficient for effective synthesis of some housekeeping (e.g., TrxRs), but not stress-related, selenoproteins. Interestingly, comparing the proband with SECISBP2-defect cases, synthesis of the essential selenoprotein GPx4 was preserved, but severely impaired ( Figure 2B ). Mice lacking the mcm 5 Um isoform exhibit reduced GPx4 levels, suggesting that both tRNA
[Ser]Sec isoforms are required for its synthesis (2); we suggest that 5-fold decreased tRNA
[Ser]Sec mcm 5 Um in the proband ( Figure 3C and Supplemental Figure 4 ) also contributed to reduced GPx4 in his case. primary cells. Compared with the control, mcm 5 U levels (peak I) were virtually unchanged, with some reduction of mcm 5 Um (peak II) in the heterozygous parent; in the proband, disproportionately greater (5-fold) diminution in tRNA
[Ser]Sec mcm 5 Um levels was observed ( Figure 3C ).
The final step in tRNA [Ser] Sec maturation, with methylation of mcm 5 U at position U34, requires other prior base modifications (e.g., pseudouridine [pψ] and 1-methyladenosine [pm1A] at positions 55 and 58, respectively) (7), intact secondary and tertiary structures (10) , and aminoacylation of tRNA [Ser] Sec (11) . To investigate base modifications, radiolabeled tRNA
[Ser]Sec transcripts were injected into Xenopus oocytes and analyzed chromatographically, indicating significantly attenuated modifications (mcm 5 Um at position U34 [peak III in Supplemental Figure 4B ] and i6A at position 37 [peak III in Supplemental Figure 4A ]) in C65G tRNA
[Ser]Sec compared with WT, confirming that maturation of mutant tRNA [Ser] Sec is indeed impaired. Additional studies showed that the C65G tRNA
[Ser]Sec mutation does not perturb initial tRNA
[Ser]Sec aminoacylation with serine or Sec synthesis and may even enhance binding to SEPSECS (Supplemental Figure 5 , A-C, and see Figure 1) ; thus, major structural differences between mutant and WT tRNA [Ser] Sec , which would have abrogated these early steps in tRNA [Ser] Sec generation, are unlikely. In complementation studies, expression of WT tRNA We have described what we believe is the first mutation in a nuclear genome-encoded, human tRNA associated with a 
Methods
Further methods are detailed in Supplemental Methods. Statistics. In studies in which statistical analyses were performed, a 2-tailed Student's t test was used to generate P values. P values less than or equal to 0.05 were considered significant.
Study approval. All investigations were part of an ethically approved protocol (Cambridgeshire LREC 98/154) and/or were clinically indicated and undertaken with prior informed patient consent.
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ES, DH, and KC designed the study. CM, EG, FM, NS, and GL recruited and clinically characterized patients. EB and SF undertook SNP genotyping and bioinformatic analysis of data. OR performed Sanger sequence analysis and interpretation of data. ES, MA, RP, and PG quantified selenoproteins. ES, BC, and RT anaIn patients with global selenoprotein deficiency due to defective SECISBP2, many features (e.g., photosensitivity, agedependent hearing loss) are attributed to ROS-mediated damage, secondary to loss of antioxidant defence (4) . It remains to be seen whether such phenotypes are ameliorated in our mutant tRNA [Ser] Sec patient, in whom synthesis of some antioxidant selenoenzymes (e.g., TrxRs, GPx4) is preserved. It is well recognized that systemic selenium status influences relative proportions of mutant tRNA [Ser] Sec isoforms, where mcm 5 Um is enriched in the Se-replete state and poorly expressed in Se deficiency (7) (8) (9) . Should careful studies altering the selenium status of patient-derived cells in vitro verify that selective selenoprotein deficits can indeed be corrected without undue toxicity, intervention with selenium supplementation in vivo could be a therapeutic possibility. 
